HOME >> MEDICINE >> NEWS
Johns Hopkins team finds 'ancestral' hepatitis-C virus at the root of evolution in infections

Researchers at Johns Hopkins have uncovered how a majority of the genetic changes in the hepatic-C virus, the most common cause of liver disease, allow it to evade the body's immune system during infection. Hepatitis C infection can lead to cirrhosis, cancer and even death. In a series of experiments that describe the virus' transition from an acute to chronic infection, the Hopkins team found that one-half of the virus' changes in its genome are in sites under attack by the body's immune system. As the virus evolves and these changes weaken the body's immune response, a second set of changes at other sites in the genome are reverting back to an "ancestral" set of amino acids.

"We think this piecemeal exchange is helping the virus evade the body's immune system," says study investigator and infectious disease specialist Stuart Ray, M.D., an associate professor at The Johns Hopkins University School of Medicine. "In a newly infected person, the virus may need to adopt new mutations to escape recognition by the immune system's T cells, which fight infection, but it may need to lose the mutations that had protected it in someone else. Despite pressure to change, the virus is always is restoring its shape."

The Hopkins findings, published in a pair of studies in the Journal of Experimental Medicine this week, are believed to be the first description of the precise genetic changes taking place in the virus during the acute phase of infection, when hepatitis C initially escapes the body's defenses and establishes itself in the body. As the infection moves into the chronic stage, the immune response becomes weak and less effective, but until now, no one could explain exactly why.

A second, related experiment produced similar findings when the Hopkins team partnered with researchers in Ireland to perform what is believed to be the first comparison of genetic changes across multiple genes in strains from chronically infected people to the or
'"/>

Contact: David March
dmarch1@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
9-Jun-2005


Page: 1 2 3 4 5 6

Related medicine news :

1. Johns Hopkins begins aggressive screening for superbugs in children
2. Johns Hopkins develops pancreas cancer risk model
3. March of Dimes, Johnson & Johnson Pediatric Institute launch prematurity prevention partnership
4. Diagnosis and referrals for kidney disease fall well short of need, Johns Hopkins study shows
5. Johns Hopkins Childrens Center to lead largest-ever study on kidney disease in children
6. Johns Hopkins lab scientists tame overactive CF protein
7. Two tests better than one for diabetes control, Johns Hopkins expert tells doctors
8. Johns Hopkins scientists exploit novel route to reverse enlarged hearts in obese mice
9. Johns Hopkins scientists map brain area that may aid hunt for human brain stem cells
10. Johns Hopkins study suggests link between caffeine dependence and family history of alcoholism
11. Johns Hopkins flu expert calls for mandatory vaccination of health care workers

Post Your Comments:
(Date:5/20/2013)... exposure to traffic-related air pollution was significantly associated ... to new research from the University of Cincinnati ... The research is detailed in a study being ... Perspectives , a peer-reviewed open access journal published ... an institute within the National Institutes of Health ...
(Date:5/20/2013)... 2013 For the third consecutive ... of Frederick Award in the Professional Standards Review ... , The USCA "Best of Local Business" Award ... Each year, the USCA identifies companies that they ... local community and business category. These are local ...
(Date:5/20/2013)... May 20, 2013 The new healthcare ... and health of all Americans. However, not all the ... impact as some might take up to 2014 to ... Services (HHS), some states are currently moving forward to ... Marketplaces, such as: Iowa, Michigan, New Hampshire, and West ...
(Date:5/20/2013)... Denver, Colorado (PRWEB) May 20, 2013 Daily ... willing to provide its readers with useful tips that can ... vitiligo. , According to the website Natural Vitiligo ... due to the numerous positive reviews it has received from ... a secret until now, but Daily Gossip has interviewed some ...
(Date:5/20/2013)... Australia (PRWEB) May 21, 2013 People are ... next. Stress levels are through the roof and are ... people handle this stress could mean the difference between life ... Change Begin’ event on 29 May will share valuable, practical ... wellbeing and influence the world around them for social good. ...
Breaking Medicine News(10 mins):Health News:Early-life traffic-related air pollution exposure linked to hyperactivity 2Health News:A2LA Receives 2013 Best of Frederick Award 2Health News:Review of Health Bill Impact in 2014 2Health News:Review of Health Bill Impact in 2014 3Health News:New Natural Vitiligo Treatment System That Helps People Treat Vitiligo Permanently Revealed by Daily Gossip Magazine 2Health News:Chill Out and Change the World, Say Mind Experts at V Star Bliss Event in Sydney 2
(Date:5/20/2013)... CARLSBAD, Calif. , May 20, 2013   ... today announced that its Applied Biosystems™ 3500 Dx and ... Federal Commission for Protection against Health Risks in ... marks a major extension of Life Technologies, capabilities to ... America with Sanger -based ...
(Date:5/20/2013)... May 20, 2013 Enrollment of patients with ... 2b dose-finding clinical trial of product candidate NewMet ... treatment for Type 2 diabetes. Elcelyx expects to complete ... in June. Results of the trial,s primary endpoint of ... summer, and the read-out for long-term glucose lowering and ...
(Date:5/20/2013)... , May 20, 2013  Medicare Part ... are overwhelmingly satisfied, citing lower costs, convenient access ... new survey from Hart Research Associates released today ... than 40% of Part D seniors (9.5 million) ... "Seniors like the lower costs, pharmacy ...
Breaking Medicine Technology:Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 2Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2
Cached News: